Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ODC1 | P11926 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | BLM | P54132 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | PLG | P00747 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6632838 | 0.92 | ODC1 (0.56) | ODC1LMNABLMKDM4EMAPT | |
| SCHEMBL2115160 | 0.80 | ODC1 (0.48) | ODC1LMNABLMKDM4EMAPT | |
| SCHEMBL4854796 | 0.80 | ARG2 (0.52) | ODC1LMNABLMKDM4EMAPT | |
| SCHEMBL1512916 | 0.78 | ODC1 (0.47) | ODC1LMNABLMKDM4EMAPT | |
| SCHEMBL259016 | 0.78 | FDPS (0.48) | KMT2AMEN1ALDH1A1ALOX15FDPS | |
| SCHEMBL29290 | 0.78 | LMNA (0.52) | LMNABLMPMP22NFKB1CYP2D6 | |
| SCHEMBL29359936 | 0.78 | ODC1 (0.63) | ODC1LMNABLMKDM4EMAPT | |
| SCHEMBL15315407 | 0.78 | PAOX (0.44) | ODC1LMNABLMKDM4EMAPT | |
| SCHEMBL3624118 | 0.78 | ARG1 (0.35) | ODC1LMNABLMPMP22THRB | |
| SCHEMBL1512913 | 0.78 | ODC1 (0.47) | ODC1LMNABLMKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110632227-B | Method for distinguishing Liuyang fermented soya beans, Yangjiang fermented soya beans and Yongchuan fermented soya beans | 中南林业科技大学 | 2022-03-18 | — | — | CN | claimed |
| EP-4324882-A2 | BINDERS | Knauf Insulation SPRL (BE) | 2024-02-21 | — | — | EP | disclosed |
| EP-3146010-B1 | BINDERS | KNAUF INSULATION INC (US) | 2023-12-13 | — | — | EP | disclosed |
| CN-107530396-B | Adiponectin peptidomimetics for the treatment of ophthalmic diseases | 雅利斯塔制药公司 | 2022-08-26 | — | — | CN | disclosed |
| US-11332577-B2 | Binders | KNAUF INSULATION SPRL (BE) | 2022-05-17 | — | — | US | disclosed |
| CN-112752575-A | Use of histidine, glycine and other amino acids for the prevention of insulin resistance and/or diabetes | 雀巢产品有限公司 | 2021-05-04 | — | — | CN | disclosed |
| CN-112740045-A | Markers for the risk of developing insulin resistance in childhood and adolescence | 雀巢产品有限公司 | 2021-04-30 | — | — | CN | disclosed |
| US-20190119446-A1 | BINDERS | KNAUF INSULATION, INC. | 2019-04-25 | — | — | US | disclosed |
| US-20170174836-A1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2017-06-22 | — | — | US | disclosed |
| US-20170103184-A1 | INJECTABLE FILLER | NGUYEN PHI (US) | 2017-04-13 | — | — | US | disclosed |
| EP-1188767-A1 | Isolated antioxidant peptides from casein and methods for preparing, isolating and identifying antioxidant peptides | KRAFT FOODS HOLDINGS, INC. (US) | 2002-03-20 | — | — | EP | disclosed |
| EP-1180240-A1 | PROCESS FOR UTILIZING EPITOPES RECOGNIZED BY NATURAL ANTIBODIES | Mirus Corporation (US) | 2002-02-20 | — | — | EP | disclosed |
| EP-0619732-B1 | BIODEGRADABLE POLYMERS FOR CELL TRANSPLANTATION | MASSACHUSETTS INST TECHNOLOGY (US) | 2001-01-31 | — | — | EP | disclosed |
| US-6171577-B1 | ACCESSIBLE SULFHYDRYL GROUP; AND HEXOSE MOIETY RECOGNIZED BY A MAMMALIAN LIVER RECEPTOR, WHEREIN THE HEXOSE MOIETY IS CONJUGATED TO THE ANNEXIN. | NEORX CORPORATION | 2001-01-09 | — | — | US | disclosed |
| WO-2000065350-A1 | PROCESS FOR UTILIZING EPITOPES RECOGNIZED BY NATURAL ANTIBODIES | MIRUS CORPORATION (US) | 2000-11-02 | — | — | WO | disclosed |
| EP-1001978-A1 | ANGIOTENSIN DERIVATIVES | Proteus Molecular Design Limited (GB) | 2000-05-24 | — | — | EP | disclosed |
| US-5968477-A | IMAGING AGENTS WITH SULFHYDRYL GROUPS AND HEXOSE GROUPS | NEORX CORPORATION (US) | 1999-10-19 | — | — | US | disclosed |
| WO-1998058952-A1 | ANGIOTENSIN DERIVATIVES | PROTEUS MOLECULAR DESIGN LIMITED (GB) | 1998-12-30 | — | — | WO | disclosed |
| US-5629427-A | MICROBIOCIDE, ANTITUMOR | PETERSON DWIGHT M (US) | 1997-05-13 | — | — | US | disclosed |
| US-5399665-A | Reacting an alpha-amino acid with an alpha-hydroxy acid to form a morpholinedione, polymerizing morpholinedione with Lewis acid; biologically active moieties may be coupled to the polymer | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1995-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170103184-A1 | INJECTABLE FILLER | MMP1, IDE, INHA | ODC1 4260/4885LMNA 2343/4885BLM 2041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.